FGL1 and non-small cell lung carcinoma: Overall, our research focused on the role of FGL1 in NSCLC and the mechanisms of its involvement in lymph node metastasis in stage T1 NSCLC, with the aim of developing a feasible treatment strategy targeting FGL1, supported by preliminary preclinical verification to provide evidence for identifying new immunotherapy targets.